Receive Information

Universal Biosensors (ASX:UBI)

  • Universal Biosensors (ASX:UBI) is a specialist medical diagnostics company developing and manufacturing test systems for point-of-care (POC) medical professionals and home use. UBI’s core technology is a disposable, multi-layer test strip, which uses its proprietary electrochemical sensor to rapidly and accurately measure biomarkers in the blood.
  • The first product developed by UBI with LifeScan (a Johnson & Johnson company) is a blood glucose measurement device and is on the market and generating revenues for UBI; the second product, developed in collaboration with Siemens Healthcare, has also been launched. The global point-of-care diagnostics market is estimated to be worth nearly US$17 billion a year and growing. UBI is now extending its platform technology to new POC applications.